Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis
Public ClinicalTrials.gov record NCT02347176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Tralokinumab in Adult Subjects With Moderate-to-Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of the study is to evaluate the efficacy and safety of tralokinumab in adults with atopic dermatitis
Study identification
- NCT ID
- NCT02347176
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 204 participants
Conditions and interventions
Conditions
Interventions
- Placebo Other
- Tralokinumab Dose 1 Biological
- Tralokinumab Dose 2 Biological
- Tralokinumab Dose 3 Biological
Other · Biological
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 23, 2015 (Actual)
- Primary completion
- Nov 27, 2015 (Actual)
- Completion
- Feb 5, 2016 (Actual)
- Last update posted
- May 23, 2018
2015 – 2016
United States locations
- U.S. sites
- 24
- U.S. states
- 12
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Rogers | Arkansas | 72758 | — |
| Research Site | Fremont | California | 94538 | — |
| Research Site | Fullerton | California | 92835 | — |
| Research Site | Los Angeles | California | 90045 | — |
| Research Site | Oceanside | California | 92056 | — |
| Research Site | Rancho Santa Margarita | California | 92688 | — |
| Research Site | Santa Monica | California | 90404 | — |
| Research Site | Clearwater | Florida | 33759 | — |
| Research Site | Miami | Florida | 33144 | — |
| Research Site | Worcester | Massachusetts | 01605 | — |
| Research Site | Warren | Michigan | 48088 | — |
| Research Site | Berlin | New Jersey | 08009 | — |
| Research Site | Verona | New Jersey | 07044 | — |
| Research Site | New York | New York | 10029 | — |
| Research Site | Rochester | New York | 14625 | — |
| Research Site | Portland | Oregon | 97241 | — |
| Research Site | Charleston | South Carolina | 29414 | — |
| Research Site | Houston | Texas | 77004 | — |
| Research Site | Houston | Texas | 77056 | — |
| Research Site | Pflugerville | Texas | 78660 | — |
| Research Site | San Antonio | Texas | 78218 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02347176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 23, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02347176 live on ClinicalTrials.gov.